HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,981,465 | +11.2% | 155,428 | -1.2% | 0.04% | +21.6% |
| Q2 2023 | $16,173,471 | -5.1% | 157,253 | +0.8% | 0.04% | -9.8% |
| Q1 2023 | $17,034,571 | -4.2% | 156,080 | -0.1% | 0.04% | -10.9% |
| Q4 2022 | $17,775,674 | +104.2% | 156,201 | +11.0% | 0.05% | +91.7% |
| Q3 2022 | $8,706,000 | -32.2% | 140,672 | -12.6% | 0.02% | -27.3% |
| Q2 2022 | $12,837,000 | -13.2% | 160,949 | +14.5% | 0.03% | -2.9% |
| Q1 2022 | $14,785,000 | -4.9% | 140,531 | -2.6% | 0.03% | +6.2% |
| Q4 2021 | $15,544,000 | -2.0% | 144,243 | -0.4% | 0.03% | -5.9% |
| Q3 2021 | $15,856,000 | +16.2% | 144,750 | -0.7% | 0.03% | +17.2% |
| Q2 2021 | $13,649,000 | +14.5% | 145,754 | +12.3% | 0.03% | +11.5% |
| Q1 2021 | $11,919,000 | +3.3% | 129,776 | -17.7% | 0.03% | +13.0% |
| Q4 2020 | $11,536,000 | – | 157,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |